Literature DB >> 10879605

Response to hepatitis B vaccine in HBsAg/anti-HBs negative and anti-HBc positive subjects.

M Sünbül1, H Leblebicioglu, S Esen, C Eroglu, S Barut.   

Abstract

Some anti-HBc positive subjects have been encountered in the absence of hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (anti-HBs). The aim of this study was to evaluate the response to hepatitis B vaccination in such cases. A total of 33 subjects who were HBsAg and anti-HBs negative, anti-HBc positive, with normal serum aminotransferase levels were included in the study. A recombinant hepatitis B vaccine was administered to subjects. Sera samples were obtained 1 month after each vaccination and tested for anti-HBs. HBV DNA and HBeAg were not detected in any subject. Anti-HBs levels were measured above 10 > or = mIU/ml in 48.4% of cases after the first vaccination, 63.6% after the second vaccination and 90.9% after the third vaccination. Only 3 subjects (9.1%) lacked antibody response in spite of the 3-dose vaccination. In conclusion, preventive antibody levels were obtained after HBV vaccination in most of the HBsAg, anti-HBs negative, anti-HBc positive persons.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10879605     DOI: 10.1080/00365540050165983

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  6 in total

1.  Responses to hepatitis B vaccine in isolated anti-HBc positive adults.

Authors:  Jun Yao; Wen Ren; Yongdi Chen; Zhenggang Jiang; Lingzhi Shen; Huan Shan; Xuewei Dai; Jing Li; Ying Liu; Yan Qiu; Jingjing Ren
Journal:  Hum Vaccin Immunother       Date:  2016-04-11       Impact factor: 3.452

2.  Long-term persistence of anti-HBs after hepatitis B vaccination among isolated anti-HBc positive adults in China: 8-years results.

Authors:  Wen Ren; Jing Li; Ruidong Cheng; Zikang Wu; Ying Liu; Yan Qiu; Jun Yao; Jingjing Ren
Journal:  Hum Vaccin Immunother       Date:  2020-09-11       Impact factor: 3.452

3.  Significance of anti-HBc only in blood donors: a serological and virological study after hepatitis B vaccination.

Authors:  Gianluca Gessoni; Samanta Beggio; Paolo Barin; Mosè Favarato; Claudio Galli; Sara Valverde; Massimo Boscolo Nata; Maria Monica Salvadego; Giorgio Marchiori
Journal:  Blood Transfus       Date:  2013-02-21       Impact factor: 3.443

4.  Efficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up: Efficacy of HBV vaccine in those who lost HBsAg.

Authors:  Hassan Taheri; Mohammad Reza Hasanjani Roushan; Mohammad Jafar Soleimani Amiri; Mohammad Pouralijan; Ali Bijani
Journal:  Hepat Mon       Date:  2011-02       Impact factor: 0.660

5.  Serosurveillance of vaccine preventable diseases and hepatitis C in healthcare workers from Lao PDR.

Authors:  Antony P Black; Keooudomphone Vilivong; Phonethipsavanh Nouanthong; Chanthasone Souvannaso; Judith M Hübschen; Claude P Muller
Journal:  PLoS One       Date:  2015-04-14       Impact factor: 3.240

6.  Significance of Response to Hepatitis B Recombinant Vaccine in Subjects with Isolated Antibody to Hepatitis B Core Antigen.

Authors:  Ali Bahari; Shahrokh Izadi; Zohreh Bari; Soheyla Khosravi; Bita Baghaei; Esmaeil Saneimoghadam; Farzad Firouzi; Ali Espiari; Abbas Esmaeilzadeh; Ali Mokhtarifar; Alireza Bakhshipour; Azita Ganji
Journal:  Middle East J Dig Dis       Date:  2015-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.